Limited time75% off all plans
Get the app

Glycoproteinoses

On this page

Glycoproteinoses - Sugar-Coated Chaos

  • Lysosomal storage disorders caused by deficient glycoprotein-degrading enzymes, leading to the accumulation of oligosaccharides with attached peptide fragments.

Angiokeratomas in Fucosidosis: Clinical and Histological

  • Aspartylglucosaminuria:

    • Defect: Aspartylglucosaminidase (AGA).
    • Features: Progressive neurodegeneration, coarse facies, connective tissue abnormalities, intellectual disability starting at age 2-4.
  • Fucosidosis:

    • Defect: α-L-Fucosidase (FUCA1).
    • Features: Coarse facies, growth retardation, psychomotor retardation, visceromegaly.

⭐ Angiokeratomas are a key feature of Fucosidosis, similar to Fabry disease, but Fucosidosis presents with coarser facial features and intellectual disability.

Glycoproteinoses are a group of lysosomal storage disorders caused by defects in glycoprotein degradation. This leads to the accumulation of oligosaccharides and glycopeptides in lysosomes, resulting in multisystemic clinical manifestations.

DisorderDeficient EnzymeAccumulated SubstrateKey Clinical Features
AspartylglucosaminuriaAspartylglucosaminidaseAspartylglucosamineLate-onset coarse facies, intellectual disability, angiokeratomas, macroglossia.
Fucosidosisα-L-FucosidaseFucose-containing glycolipids & oligosaccharidesCoarse facies, growth retardation, dysostosis multiplex, angiokeratomas, ↑ sweat salinity.
Schindler Diseaseα-N-Acetylgalactosaminidase (α-NAGA)Glycopeptides with α-N-acetylgalactosaminyl terminiType I (infantile): neuroaxonal dystrophy, rapid neurodegeneration. Type II (adult): milder, angiokeratoma corporis diffusum.
Sialidosis (Mucolipidosis I)α-N-Acetylneuraminidase (Sialidase)SialyloligosaccharidesType I: normal intelligence, myoclonus, ataxia, cherry-red spot. Type II: infantile onset, coarse facies, dysostosis multiplex.

Exam Favourite: The presence of a macular cherry-red spot on fundoscopy is a classic finding in Sialidosis (Type I), similar to Tay-Sachs disease, but distinguished by the associated myoclonus and normal early development.

Diagnosis & Management - The Clinician's Playbook

  • Diagnosis

    • Screening: Urinary oligosaccharide analysis.
    • Definitive Diagnosis: Enzyme activity assays in cultured fibroblasts or leukocytes.
    • Confirmation: Molecular genetic testing for specific gene mutations.
  • Management

    • Primary Approach: Symptomatic and supportive care.
      • Managing seizures, recurrent infections, and skeletal abnormalities.
    • Therapeutic Options:
      • Hematopoietic stem cell transplantation (HSCT) has shown limited success in some cases (e.g., fucosidosis).
      • Enzyme replacement therapy (ERT) and chaperone therapies are largely investigational.

Exam Favorite: Aspartylglucosaminuria has a significantly high prevalence in the Finnish population due to a founder effect.

High‑Yield Points - ⚡ Biggest Takeaways

  • Glycoproteinoses are a group of autosomal recessive disorders resulting from defects in glycoprotein catabolism.
  • This leads to lysosomal accumulation of glycans or glycopeptides, causing widespread cellular dysfunction.
  • Clinical overlap with MPS is significant: coarse facial features, dysostosis multiplex, and psychomotor retardation.
  • Distinguishing features can include angiokeratomas, hearing loss, and myoclonus.
  • Diagnosis is confirmed by detecting oligosaccharides in urine and through specific enzyme activity assays.

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS
Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Everything you need for USMLE prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE